139 related articles for article (PubMed ID: 19174612)
41. [Significance of c-erbB-2 and PCNA expression in adenocarcinoma of uterine cervix].
Huang Y; Cai S; Yu S
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):150-2. PubMed ID: 10743084
[TBL] [Abstract][Full Text] [Related]
42. [Expression level of c-erbB-2 protein correlates with the prognosis of patients with colorectal cancer].
Zhou Z; Wan D; Zhang C
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):139-41. PubMed ID: 11783020
[TBL] [Abstract][Full Text] [Related]
43. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
[TBL] [Abstract][Full Text] [Related]
44. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2005 Aug; 27(2):317-25. PubMed ID: 16010411
[TBL] [Abstract][Full Text] [Related]
45. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma.
Sirak I; Petera J; Hatlova J; Vosmik M; Melichar B; Dvorak J; Zoul Z; Tycova V; Lesko M; Hajduch M
Strahlenther Onkol; 2008 Nov; 184(11):592-7. PubMed ID: 19016018
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor receptor expression in invasive thymoma.
Henley JD; Koukoulis GK; Loehrer PJ
J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304
[TBL] [Abstract][Full Text] [Related]
48. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
Hernes E; Fosså SD; Berner A; Otnes B; Nesland JM
Br J Cancer; 2004 Jan; 90(2):449-54. PubMed ID: 14735192
[TBL] [Abstract][Full Text] [Related]
49. erbB receptor expression patterns in human bladder cancer.
Rajjayabun PH; Keegan PE; Lunec J; Mellon JK
Urology; 2005 Jul; 66(1):196-200. PubMed ID: 15992892
[TBL] [Abstract][Full Text] [Related]
50. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer.
Gazzaniga P; Nofroni I; Gandini O; Silvestri I; Frati L; Aglianò AM; Gradilone A
Oncol Rep; 2005 Nov; 14(5):1199-202. PubMed ID: 16211285
[TBL] [Abstract][Full Text] [Related]
51. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
Peláez Buján Mdel C; Ruibal Morell A; Aza González J
Rev Esp Enferm Dig; 1999 Dec; 91(12):826-37. PubMed ID: 10619912
[TBL] [Abstract][Full Text] [Related]
52. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
[TBL] [Abstract][Full Text] [Related]
53. Does c-erbB-2 expression have a role in medulloblastoma prognosis?
Bal MM; Das Radotra B; Srinivasan R; Sharma SC
Indian J Pathol Microbiol; 2006 Oct; 49(4):535-9. PubMed ID: 17183845
[TBL] [Abstract][Full Text] [Related]
54. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
[TBL] [Abstract][Full Text] [Related]
55. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
[TBL] [Abstract][Full Text] [Related]
56. Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas.
Skomedal H; Kristensen G; Holm R
Gynecol Oncol; 1995 Dec; 59(3):379-83. PubMed ID: 8522259
[TBL] [Abstract][Full Text] [Related]
57. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
[TBL] [Abstract][Full Text] [Related]
58. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
Nose N; Sugio K; Oyama T; Nozoe T; Uramoto H; Iwata T; Onitsuka T; Yasumoto K
J Clin Oncol; 2009 Jan; 27(3):411-7. PubMed ID: 19064969
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of basal-like subtype in triple-negative breast cancer.
Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
[TBL] [Abstract][Full Text] [Related]
60. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]